Article
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007-21.
The Journal of antimicrobial chemotherapy - 1 Oct 2024
Schellenberg John J, Adam Heather J, Baxter Melanie R, Karlowsky James A, Golden Alyssa R, Martin Irene, Zhanel George G
Abstract excerpt
BACKGROUND: Lower respiratory infections and invasive disease caused by Streptococcus pneumoniae serotype 3 remain major clinical challenges around the world, despite widespread availability of updated vaccines. METHODS: As part of CANWARD, antimicrobial susceptibility testing and serotyping were performed on all S. pneumoniae isolates from 2007 to 2021. A subset of 226/264 (85.6%) serotype 3 isolates were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
